LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

2.03 3.05

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.02

Max

2.03

Schlüsselkennzahlen
By Trading Economics
Angestellte	26

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-5M 15M
Vorheriger Eröffnungskurs	-1.02
Vorheriger Schlusskurs	2.03

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Dez. 2025, 17:29 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19. Dez. 2025, 16:47 UTC

Wichtige Markttreiber

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19. Dez. 2025, 16:10 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

21. Dez. 2025, 23:51 UTC

Market Talk

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

21. Dez. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. Dez. 2025, 23:45 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

21. Dez. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

19. Dez. 2025, 22:33 UTC

Ergebnisse

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19. Dez. 2025, 22:19 UTC

Ergebnisse

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19. Dez. 2025, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19. Dez. 2025, 21:44 UTC

Ergebnisse

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19. Dez. 2025, 21:38 UTC

Ergebnisse

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19. Dez. 2025, 21:00 UTC

Market Talk

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19. Dez. 2025, 20:23 UTC

Market Talk

Oil Futures End Down Week on Up Note -- Market Talk

19. Dez. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19. Dez. 2025, 18:38 UTC

Market Talk

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19. Dez. 2025, 18:00 UTC

Market Talk

Ergebnisse

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19. Dez. 2025, 17:41 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19. Dez. 2025, 17:24 UTC

Market Talk

Ergebnisse

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19. Dez. 2025, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

19. Dez. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

19. Dez. 2025, 16:29 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19. Dez. 2025, 16:20 UTC

Akquisitionen, Fusionen, Übernahmen

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19. Dez. 2025, 16:19 UTC

Akquisitionen, Fusionen, Übernahmen

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19. Dez. 2025, 16:18 UTC

Akquisitionen, Fusionen, Übernahmen

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19. Dez. 2025, 16:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19. Dez. 2025, 16:16 UTC

Market Talk

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19. Dez. 2025, 16:05 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19. Dez. 2025, 16:04 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19. Dez. 2025, 15:37 UTC

Market Talk

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.